MedPath

Chloral hydrate

Generic Name
Chloral hydrate
Brand Names
Nortec
Drug Type
Small Molecule
Chemical Formula
C2H3Cl3O2
CAS Number
302-17-0
Unique Ingredient Identifier
418M5916WG
Background

A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.

Indication

Mainly used as a hypnotic in the treatment of insomnia; however, it is only effective as a hypnotic for short-term use. May be used as a routine sedative preoperatively to decrease anxiety and cause sedation and/or sleep with respiration depression or cough reflex.

Associated Conditions
Alcohol Withdrawal Syndrome, Opioid Withdrawal (Disorder), Postoperative pain, Barbiturate withdrawal
Associated Therapies
Sedative therapy

A Comparison Between Oral Melatonin With Nasal Sevoflurane Versus Oral Chloral Hydrate With Nasal Sevoflurane in Sedation of Children Undergoing Brain MRI

Phase 4
Completed
Conditions
Sedation for Children Undergoing MRI
Interventions
First Posted Date
2024-09-23
Last Posted Date
2025-01-01
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT06606899
Locations
🇪🇬

Ain shams university hospitals, Cairo, Egypt

An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia

Phase 4
Completed
Conditions
Chloral Hydrate
Insomnia
Insomnia Chronic
Interventions
First Posted Date
2023-09-26
Last Posted Date
2024-11-07
Lead Sponsor
Pharmanovia
Target Recruit Count
100
Registration Number
NCT06053840
Locations
🇬🇧

Lindus Health, The Leather Market Weston Street, Bermondsey,, London, United Kingdom

Sedation and Nursing Management in EEG Recording in Children

Not Applicable
Completed
Conditions
Electroencephalography
Melatonin
Chloral Hydrate
Hydroxyzine
Sleep Deprivation
Interventions
Other: Sedation and Nursing Management in EEG Recording in Children
First Posted Date
2022-08-09
Last Posted Date
2022-08-09
Lead Sponsor
Suleyman Demirel University
Target Recruit Count
180
Registration Number
NCT05492812
Locations
🇹🇷

Suleyman Demirel University, Isparta, Turkey

Dexmedetomidine in Children Having Transthoracic Echocardiography

Phase 4
Completed
Conditions
Heart Disease
Interventions
First Posted Date
2015-08-14
Last Posted Date
2017-07-31
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Target Recruit Count
279
Registration Number
NCT02523144
Locations
🇨🇳

Shanghai Children's Hospital, Shanghai, China

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children

Phase 3
Completed
Conditions
Sedation
Epilepsy
Electroencephalogram
Children
Interventions
Dietary Supplement: Melatonin
First Posted Date
2014-07-21
Last Posted Date
2017-11-30
Lead Sponsor
University of Cape Town
Target Recruit Count
194
Registration Number
NCT02195661
Locations
🇿🇦

Red Cross War Memorial Children's Hospital, Cape Town, Western Cape, South Africa

Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam

Phase 2
Withdrawn
Conditions
Traumatic Brain Injury
Computed Tomography
Procedural Sedation
Interventions
First Posted Date
2011-07-26
Last Posted Date
2013-06-20
Lead Sponsor
University of Sao Paulo
Registration Number
NCT01402596
Locations
🇧🇷

University of Sao Paulo, Sao Paulo, SP, Brazil

A Trial Of Oral Chloral Hydrate Versus Intranasal Dexmedetomidine For Sedated Abr Exams

Phase 4
Completed
Conditions
Sedation
Interventions
Other: Intranasal placebo
Other: Oral placebo
First Posted Date
2010-12-08
Last Posted Date
2016-05-16
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
90
Registration Number
NCT01255904
Locations
🇺🇸

Texas Childrens Hospital, Houston, Texas, United States

Effects of Chloral Hydrate on Induction, Maintenance, and Recovery From Sevoflurane Anesthesia in Day-case Pediatric Surgery

Not Applicable
Completed
Conditions
Pediatric
Interventions
First Posted Date
2010-06-28
Last Posted Date
2011-06-10
Lead Sponsor
Yonsei University
Target Recruit Count
100
Registration Number
NCT01149226
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

Phase 3
Completed
Conditions
Other Conditions of Brain
Interventions
First Posted Date
2010-03-10
Last Posted Date
2013-10-25
Lead Sponsor
Federal University of Minas Gerais
Target Recruit Count
25
Registration Number
NCT01083797
Locations
🇧🇷

Santa Casa de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil

© Copyright 2025. All Rights Reserved by MedPath